Cargando…
Complete and Sustained Response with a Doublet Chemotherapy Protocol in an 81-Year-Old Patient with Metastatic Breast Cancer
Metastatic breast cancer (MBC) entails an overall 5-year survival of approximately 25%. The choice of therapy is influenced by expression of the HER2 gene and hormone receptors, by a disease-free interval, and by age. The use of paclitaxel combined with gemcitabine (doublet protocol) has shown effic...
Autores principales: | Puty, Taynah Cascaes, Brito, Gabriel S.A., Dias, Mariana S., Miranda, Henrique C., Chaves, Juliana R., Freitas, Heryvelton L., Carvalho, Luís E.W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118833/ https://www.ncbi.nlm.nih.gov/pubmed/27920688 http://dx.doi.org/10.1159/000449127 |
Ejemplares similares
-
Evaluation of the impact of single-nucleotide polymorphisms on treatment response, survival and toxicity with cytarabine and anthracyclines in patients with acute myeloid leukaemia: a systematic review protocol
por: Puty, Taynah Cascaes, et al.
Publicado: (2019) -
On the (s$_{1/2}^{-1}$ p$_{1/2}^{-1}$) doublet in $^{206}_{81}$Tl$_{125}$
por: Astner, G, et al.
Publicado: (1970) -
On the $ doublet in $
por: Astner, G, et al.
Publicado: (1970) -
Protocol for Identification and Removal of Doublets with DoubletDecon
por: DePasquale, Erica A.K., et al.
Publicado: (2020) -
An 81 Year Old with Back Pain
por: Dubb, Sukhpreet S., et al.
Publicado: (2013)